Company Logo The Cancer Molecular Diagnostics market is seeing accelerated growth driven by trends like personalized medicine, pharmacogenomics, and liquid biopsy. Key opportunities lie in companion ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Breast cancer detection technologies have evolved from conventional histopathology to advanced molecular methods to offer diagnostic insights, informs Ajay Kandhari, managing director, DSS Imagetech ...

Roche’s diagnostics business continues to be buffeted by China headwinds, but the Swiss major believes it has enough ...

India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are ...

Insight Molecular Diagnostics Inc. (($IMDX)) announced an update on their ongoing clinical study. Study Overview: The GraftAssureDx Study, ...